Protecting the brain of term infants: from bench to bedside
Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
O'Hare, S. Samantha [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood - Hinchliff, Gemma L.M. ELSEVIER, 2016, Amsterdam |
|---|---|
| Übergeordnetes Werk: |
volume:24 ; year:2014 ; number:9 ; pages:390-396 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.paed.2014.04.005 |
|---|
| Katalog-ID: |
ELV039310086 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV039310086 | ||
| 003 | DE-627 | ||
| 005 | 20230625224616.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.paed.2014.04.005 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014009000007.pica |
| 035 | |a (DE-627)ELV039310086 | ||
| 035 | |a (ELSEVIER)S1751-7222(14)00087-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 630 |q VZ |
| 082 | 0 | 4 | |a 640 |q VZ |
| 082 | 0 | 4 | |a 590 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 600 |q VZ |
| 084 | |a 50.70 |2 bkl | ||
| 100 | 1 | |a O'Hare, S. Samantha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Protecting the brain of term infants: from bench to bedside |
| 264 | 1 | |c 2014transfer abstract | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. | ||
| 520 | |a Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. | ||
| 650 | 7 | |a neonatal encephalopathy |2 Elsevier | |
| 650 | 7 | |a neuroprotection |2 Elsevier | |
| 650 | 7 | |a hypoxic-ischaemic encephalopathy |2 Elsevier | |
| 650 | 7 | |a therapeutic hypothermia |2 Elsevier | |
| 650 | 7 | |a neurocritical care |2 Elsevier | |
| 700 | 1 | |a Austin, Topun |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Hinchliff, Gemma L.M. ELSEVIER |t Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood |d 2016 |g Amsterdam |w (DE-627)ELV024210234 |
| 773 | 1 | 8 | |g volume:24 |g year:2014 |g number:9 |g pages:390-396 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.paed.2014.04.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_50 | ||
| 912 | |a GBV_ILN_176 | ||
| 912 | |a GBV_ILN_181 | ||
| 912 | |a GBV_ILN_203 | ||
| 912 | |a GBV_ILN_227 | ||
| 912 | |a GBV_ILN_235 | ||
| 912 | |a GBV_ILN_352 | ||
| 912 | |a GBV_ILN_665 | ||
| 912 | |a GBV_ILN_677 | ||
| 936 | b | k | |a 50.70 |j Energie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 24 |j 2014 |e 9 |h 390-396 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
s s o ss sso |
|---|---|
| matchkey_str |
oharessamanthaaustintopun:2014----:rtcighbanfemnatfob |
| hierarchy_sort_str |
2014transfer abstract |
| bklnumber |
50.70 |
| publishDate |
2014 |
| allfields |
10.1016/j.paed.2014.04.005 doi GBVA2014009000007.pica (DE-627)ELV039310086 (ELSEVIER)S1751-7222(14)00087-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 VZ 640 VZ 590 VZ 610 VZ 600 VZ 50.70 bkl O'Hare, S. Samantha verfasserin aut Protecting the brain of term infants: from bench to bedside 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care Elsevier Austin, Topun oth Enthalten in Elsevier Hinchliff, Gemma L.M. ELSEVIER Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood 2016 Amsterdam (DE-627)ELV024210234 volume:24 year:2014 number:9 pages:390-396 extent:7 https://doi.org/10.1016/j.paed.2014.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_50 GBV_ILN_176 GBV_ILN_181 GBV_ILN_203 GBV_ILN_227 GBV_ILN_235 GBV_ILN_352 GBV_ILN_665 GBV_ILN_677 50.70 Energie: Allgemeines VZ AR 24 2014 9 390-396 7 045F 610 |
| spelling |
10.1016/j.paed.2014.04.005 doi GBVA2014009000007.pica (DE-627)ELV039310086 (ELSEVIER)S1751-7222(14)00087-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 VZ 640 VZ 590 VZ 610 VZ 600 VZ 50.70 bkl O'Hare, S. Samantha verfasserin aut Protecting the brain of term infants: from bench to bedside 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care Elsevier Austin, Topun oth Enthalten in Elsevier Hinchliff, Gemma L.M. ELSEVIER Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood 2016 Amsterdam (DE-627)ELV024210234 volume:24 year:2014 number:9 pages:390-396 extent:7 https://doi.org/10.1016/j.paed.2014.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_50 GBV_ILN_176 GBV_ILN_181 GBV_ILN_203 GBV_ILN_227 GBV_ILN_235 GBV_ILN_352 GBV_ILN_665 GBV_ILN_677 50.70 Energie: Allgemeines VZ AR 24 2014 9 390-396 7 045F 610 |
| allfields_unstemmed |
10.1016/j.paed.2014.04.005 doi GBVA2014009000007.pica (DE-627)ELV039310086 (ELSEVIER)S1751-7222(14)00087-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 VZ 640 VZ 590 VZ 610 VZ 600 VZ 50.70 bkl O'Hare, S. Samantha verfasserin aut Protecting the brain of term infants: from bench to bedside 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care Elsevier Austin, Topun oth Enthalten in Elsevier Hinchliff, Gemma L.M. ELSEVIER Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood 2016 Amsterdam (DE-627)ELV024210234 volume:24 year:2014 number:9 pages:390-396 extent:7 https://doi.org/10.1016/j.paed.2014.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_50 GBV_ILN_176 GBV_ILN_181 GBV_ILN_203 GBV_ILN_227 GBV_ILN_235 GBV_ILN_352 GBV_ILN_665 GBV_ILN_677 50.70 Energie: Allgemeines VZ AR 24 2014 9 390-396 7 045F 610 |
| allfieldsGer |
10.1016/j.paed.2014.04.005 doi GBVA2014009000007.pica (DE-627)ELV039310086 (ELSEVIER)S1751-7222(14)00087-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 VZ 640 VZ 590 VZ 610 VZ 600 VZ 50.70 bkl O'Hare, S. Samantha verfasserin aut Protecting the brain of term infants: from bench to bedside 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care Elsevier Austin, Topun oth Enthalten in Elsevier Hinchliff, Gemma L.M. ELSEVIER Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood 2016 Amsterdam (DE-627)ELV024210234 volume:24 year:2014 number:9 pages:390-396 extent:7 https://doi.org/10.1016/j.paed.2014.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_50 GBV_ILN_176 GBV_ILN_181 GBV_ILN_203 GBV_ILN_227 GBV_ILN_235 GBV_ILN_352 GBV_ILN_665 GBV_ILN_677 50.70 Energie: Allgemeines VZ AR 24 2014 9 390-396 7 045F 610 |
| allfieldsSound |
10.1016/j.paed.2014.04.005 doi GBVA2014009000007.pica (DE-627)ELV039310086 (ELSEVIER)S1751-7222(14)00087-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 VZ 640 VZ 590 VZ 610 VZ 600 VZ 50.70 bkl O'Hare, S. Samantha verfasserin aut Protecting the brain of term infants: from bench to bedside 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care Elsevier Austin, Topun oth Enthalten in Elsevier Hinchliff, Gemma L.M. ELSEVIER Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood 2016 Amsterdam (DE-627)ELV024210234 volume:24 year:2014 number:9 pages:390-396 extent:7 https://doi.org/10.1016/j.paed.2014.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_50 GBV_ILN_176 GBV_ILN_181 GBV_ILN_203 GBV_ILN_227 GBV_ILN_235 GBV_ILN_352 GBV_ILN_665 GBV_ILN_677 50.70 Energie: Allgemeines VZ AR 24 2014 9 390-396 7 045F 610 |
| language |
English |
| source |
Enthalten in Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood Amsterdam volume:24 year:2014 number:9 pages:390-396 extent:7 |
| sourceStr |
Enthalten in Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood Amsterdam volume:24 year:2014 number:9 pages:390-396 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Energie: Allgemeines |
| institution |
findex.gbv.de |
| topic_facet |
neonatal encephalopathy neuroprotection hypoxic-ischaemic encephalopathy therapeutic hypothermia neurocritical care |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood |
| authorswithroles_txt_mv |
O'Hare, S. Samantha @@aut@@ Austin, Topun @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV024210234 |
| dewey-sort |
3610 |
| id |
ELV039310086 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039310086</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625224616.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.paed.2014.04.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014009000007.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039310086</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1751-7222(14)00087-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">590</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">O'Hare, S. Samantha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protecting the brain of term infants: from bench to bedside</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neonatal encephalopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neuroprotection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">hypoxic-ischaemic encephalopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapeutic hypothermia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neurocritical care</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Austin, Topun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hinchliff, Gemma L.M. ELSEVIER</subfield><subfield code="t">Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV024210234</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:24</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:390-396</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.paed.2014.04.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_50</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_176</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_203</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_227</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_235</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_352</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_665</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_677</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.70</subfield><subfield code="j">Energie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">24</subfield><subfield code="j">2014</subfield><subfield code="e">9</subfield><subfield code="h">390-396</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
O'Hare, S. Samantha |
| spellingShingle |
O'Hare, S. Samantha ddc 610 ddc 630 ddc 640 ddc 590 ddc 600 bkl 50.70 Elsevier neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care Protecting the brain of term infants: from bench to bedside |
| authorStr |
O'Hare, S. Samantha |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV024210234 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 630 - Agriculture & related technologies 640 - Home & family management 590 - Animals (Zoology) 600 - Technology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 630 VZ 640 VZ 590 VZ 610 VZ 600 VZ 50.70 bkl Protecting the brain of term infants: from bench to bedside neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care Elsevier |
| topic |
ddc 610 ddc 630 ddc 640 ddc 590 ddc 600 bkl 50.70 Elsevier neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care |
| topic_unstemmed |
ddc 610 ddc 630 ddc 640 ddc 590 ddc 600 bkl 50.70 Elsevier neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care |
| topic_browse |
ddc 610 ddc 630 ddc 640 ddc 590 ddc 600 bkl 50.70 Elsevier neonatal encephalopathy Elsevier neuroprotection Elsevier hypoxic-ischaemic encephalopathy Elsevier therapeutic hypothermia Elsevier neurocritical care |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t a ta |
| hierarchy_parent_title |
Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood |
| hierarchy_parent_id |
ELV024210234 |
| dewey-tens |
610 - Medicine & health 630 - Agriculture 640 - Home & family management 590 - Animals (Zoology) 600 - Technology |
| hierarchy_top_title |
Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV024210234 |
| title |
Protecting the brain of term infants: from bench to bedside |
| ctrlnum |
(DE-627)ELV039310086 (ELSEVIER)S1751-7222(14)00087-0 |
| title_full |
Protecting the brain of term infants: from bench to bedside |
| author_sort |
O'Hare, S. Samantha |
| journal |
Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood |
| journalStr |
Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
390 |
| author_browse |
O'Hare, S. Samantha |
| container_volume |
24 |
| physical |
7 |
| class |
610 610 DE-600 630 VZ 640 VZ 590 VZ 610 VZ 600 VZ 50.70 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
O'Hare, S. Samantha |
| doi_str_mv |
10.1016/j.paed.2014.04.005 |
| dewey-full |
610 630 640 590 600 |
| title_sort |
protecting the brain of term infants: from bench to bedside |
| title_auth |
Protecting the brain of term infants: from bench to bedside |
| abstract |
Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. |
| abstractGer |
Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. |
| abstract_unstemmed |
Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_50 GBV_ILN_176 GBV_ILN_181 GBV_ILN_203 GBV_ILN_227 GBV_ILN_235 GBV_ILN_352 GBV_ILN_665 GBV_ILN_677 |
| container_issue |
9 |
| title_short |
Protecting the brain of term infants: from bench to bedside |
| url |
https://doi.org/10.1016/j.paed.2014.04.005 |
| remote_bool |
true |
| author2 |
Austin, Topun |
| author2Str |
Austin, Topun |
| ppnlink |
ELV024210234 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.paed.2014.04.005 |
| up_date |
2024-07-06T20:18:23.084Z |
| _version_ |
1803862255163408384 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039310086</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625224616.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.paed.2014.04.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014009000007.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039310086</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1751-7222(14)00087-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">590</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">O'Hare, S. Samantha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protecting the brain of term infants: from bench to bedside</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neonatal encephalopathy is a major cause of death and lifelong neurodisability. Until recently the only treatment option for infants suffering from hypoxic-ischaemic encephalopathy was supportive intensive care. Therapeutic hypothermia has been shown to reduce death and disability, and significantly increase the number of infants with normal neurodevelopmental outcome at 18 months of age. Its introduction into standard clinical practice follows over 20 years of research from basic experimental science through to multi-centre randomised controlled trials. Hypothermia should be achieved promptly, and active cooling methods during neonatal transport have been shown to reduce stabilization and transfer times to regional cooling centres. Cerebral function monitoring is an important tool to assess severity of injury and monitor seizures; magnetic resonance imaging provides the best early prognostic information. New adjunct therapies, such as inhaled xenon and melatonin, show promise and are currently in various stages of experimental and clinical evaluation.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neonatal encephalopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neuroprotection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">hypoxic-ischaemic encephalopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapeutic hypothermia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neurocritical care</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Austin, Topun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hinchliff, Gemma L.M. ELSEVIER</subfield><subfield code="t">Risky dieting amongst adolescent girls: Associations with family relationship problems and depressed mood</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV024210234</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:24</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:390-396</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.paed.2014.04.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_50</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_176</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_203</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_227</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_235</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_352</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_665</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_677</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.70</subfield><subfield code="j">Energie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">24</subfield><subfield code="j">2014</subfield><subfield code="e">9</subfield><subfield code="h">390-396</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401761 |